We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
-11.33%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$15.1B
AUM Growth
-$1.81B
(-11%)
Cap. Flow
+$464M
Cap. Flow
% of AUM
3.07%
Top 10 Holdings %
Top 10 Hldgs %
22.68%
Holding
1,302
New
77
Increased
452
Reduced
571
Closed
126
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$835M |
| 2 |
Procter & Gamble
PG
|
+$87.9M |
| 3 |
Alibaba
BABA
|
+$50.4M |
| 4 |
Merck
MRK
|
+$47.1M |
| 5 |
Target
TGT
|
+$42.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$105M |
| 2 |
Texas Instruments
TXN
|
+$79.4M |
| 3 |
TSMC
TSM
|
+$77.5M |
| 4 |
Cisco
CSCO
|
+$55.8M |
| 5 |
NextEra Energy
NEE
|
+$47.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.2% |
| 2 | Healthcare | 16.02% |
| 3 | Financials | 13.93% |
| 4 | Communication Services | 9.97% |
| 5 | Consumer Discretionary | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Halozyme
HALO
$12.1B
| $323K | ﹤0.01% |
22,500
-5,000
| -18% | -$79.8K |
|
902
ICL Group
ICL
$6.94B
| $317K | ﹤0.01% |
57,222
+38,221
| +201% | +$226K |
|
903
National Fuel Gas
NFG
$7.7B
| $317K | ﹤0.01% |
6,100
| – | – |
|
|
DOO
904
Bombardier Recreational Products
DOO
$4.73B
| $313K | ﹤0.01% |
12,176
| – | – |
|
905
Ovintiv
OVV
$17.4B
| $313K | ﹤0.01% |
10,773
+4,806
| +81% | +$207K |
|
906
RenaissanceRe
RNR
$13.4B
| $312K | ﹤0.01% |
2,206
-1,490
| -40% | -$195K |
|
907
Amphastar Pharmaceuticals
AMPH
$873M
| $307K | ﹤0.01% |
15,400
-3,300
| -18% | -$65K |
|
908
Utah Medical Products
UTMD
$228M
| $307K | ﹤0.01% |
+3,950
| New | +$348K |
|
909
EastGroup Properties
EGP
$10.8B
| $306K | ﹤0.01% |
3,324
| – | – |
|
910
Methanex
MEOH
$4.25B
| $304K | ﹤0.01% |
6,213
-1,287
| -17% | -$80.3K |
|
911
Under Armour
UAA
$2.4B
| $301K | ﹤0.01% |
16,375
+1,121
| +7% | +$23K |
|
912
Jefferies Financial Group
JEF
$13B
| $300K | ﹤0.01% |
17,963
-998
| -5% | -$18.3K |
|
913
Boston Beer
SAM
$1.87B
| $297K | ﹤0.01% |
1,206
+198
| +20% | +$55.4K |
|
914
Fate Therapeutics
FATE
$323M
| $293K | ﹤0.01% |
+25,000
| New | +$349K |
|
915
Keurig Dr Pepper
KDP
$39.7B
| $292K | ﹤0.01% |
11,451
-40,831
| -78% | -$1.04M |
|
916
Iovance Biotherapeutics
IOVA
$2.91B
| $288K | ﹤0.01% |
32,500
-57,500
| -64% | -$555K |
|
|
STOR
917
DELISTED
STORE Capital Corporation
STOR
| $288K | ﹤0.01% |
10,016
+4,153
| +71% | +$121K |
|
|
AIMT
918
DELISTED
Aimmune Therapeutics
AIMT
| $286K | ﹤0.01% |
12,400
-2,700
| -18% | -$69.9K |
|
919
Banco Santander Chile
BSAC
$16.6B
| $285K | ﹤0.01% |
9,576
| – | – |
|
920
Twilio
TWLO
$38B
| $285K | ﹤0.01% |
3,262
+590
| +22% | +$47.9K |
|
921
Chemours
CC
$2.23B
| $284K | ﹤0.01% |
9,490
-14,148
| -60% | -$448K |
|
922
U-Haul Holding Co
UHAL
$14.6B
| $284K | ﹤0.01% |
8,300
+2,450
| +42% | +$82.8K |
|
923
TherapeuticsMD
TXMD
$24M
| $283K | ﹤0.01% |
1,430
-320
| -18% | -$78.1K |
|
924
First Industrial Realty Trust
FR
$8.33B
| $282K | ﹤0.01% |
9,900
-2,100
| -18% | -$65K |
|
925
Under Armour Class C
UA
$2.36B
| $282K | ﹤0.01% |
16,799
+1,240
| +8% | +$23.5K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q4 2018 Portfolio in Review
As of Q4 2018, DekaBank Deutsche Girozentrale held 1,302 positions worth $15.1B, down 11% from $16.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
DekaBank Deutsche Girozentrale deployed $464M of net new capital in Q4 2018, opening 77 new positions and adding to 452 existing holdings. Its largest new stake was Linde: 5,283,074 shares worth $840M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $105M trimmed.
- DekaBank Deutsche Girozentrale's largest Q4 2018 buy was Linde: 5,283,074 shares worth $840M.
- DekaBank Deutsche Girozentrale added most to Procter & Gamble in Q4 2018, an estimated $87.9M increase.
- DekaBank Deutsche Girozentrale's biggest Q4 2018 reduction was Johnson & Johnson, cutting an estimated $105M.
- DekaBank Deutsche Girozentrale fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $46.5M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 23% of its $15.1B portfolio in Q4 2018.
- DekaBank Deutsche Girozentrale opened 77 new positions and closed 126 in Q4 2018.
- DekaBank Deutsche Girozentrale's portfolio value fell 11% quarter-over-quarter to $15.1B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2018, filed 12 Feb 2019.